Novo to spend 265 million of Wegovy’s revenues on respiratory diseases
The Novo Nordisk Foundation, which controls drug maker Novo Nordisk, said Monday the government will allocate up to 1.8 billion Danish kroner ($265 million) for an initiative aimed at improving vaccines against respiratory diseases.
POPULAR POSTS
Bangladesh dengue deaths top 400
November 18, 2024
FDA approves Syndax blood cancer drug
November 18, 2024
CDC confirms first human case of bird flu in Oregon
November 18, 2024
LIVE STREAM
